A New Antileishmanial Preparation of Combined Solamargine and Solasonine Heals Cutaneous Leishmaniasis through Different Immunochemical Pathways
- 1 May 2016
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 60 (5) , 2732-2738
Abstract
Little has been done during the past 100 years to develop new antileishmanial drugs. Most infected individuals live in poor countries and have a low cash income to be attractive targets to pharmaceutical corporations. Two heterosidic steroids, solamargine and solasonine, initially identified as major components of the Brazilian plant Solanum lycocarpum , were tested for leishmanicidal activity. Both alkaloids killed intracellular and extracellular Leishmania mexicana parasites more efficiently than the reference drug sodium stibogluconate. A total of 10 μM each individual alkaloid significantly reduced parasite counts in infected macrophages and dendritic cells. In vivo treatment of C57BL/6 mice with a standardized topical preparation containing solamargine (45.1%) and solasonine (44.4%) gave significant reductions in lesion sizes and parasite counts recovered from lesions. Alkaloids present different immunochemical pathways in macrophages and dendritic cells. We conclude that this topical preparation is effective and a potential new and inexpensive treatment for cutaneous leishmaniasis.Keywords
Funding Information
- CONACYT MEXICO (Fondo Sectorial de Salud 140091)
- Sao Paolo Research Foundation (FAPESP)
This publication has 28 references indexed in Scilit:
- New World and Old World Leishmania InfectionsDermatologic Clinics, 2015
- Effectiveness and Safety of Short Course Liposomal Amphotericin B (AmBisome) as First Line Treatment for Visceral Leishmaniasis in BangladeshPLOS Neglected Tropical Diseases, 2015
- Miltefosine for Visceral and Cutaneous Leishmaniasis: Drug Characteristics and Evidence-Based Treatment RecommendationsClinical Infectious Diseases, 2015
- In vitro and in vivo evaluation of the delivery of topical formulations containing glycoalkaloids of Solanum lycocarpum fruitsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2014
- Detection of Drug Resistance Gene in Cutaneous Leishmaniasis by PCR in Some Endemic Areas of Iran2011
- Antimutagenic Potential ofSolanum lycocarpumagainst Induction of Chromosomal Aberrations in V79 Cells and Micronuclei in Mice by DoxorubicinPlanta Medica, 2011
- Leishmanicidal activity of racemic ± 8-[(4-Amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinolineNatural Product Communications, 2010
- Biological activity of alkaloids fromSolanum dulcamaraL.Natural Product Research, 2009
- Developmental Toxicology of Solamargine and Solasonine Glycoalkaloids in Frog EmbryosFood and Chemical Toxicology, 1998
- The inactivation of herpes simplex virus by some Solanaceae glycoalkaloidsAntiviral Research, 1985